PA Medical News about Reversible Pancytopenia

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. Recommendations on the use of 18F-FDG PET in oncology

3. Use of Antiemetic Agents in Acute Gastroenteritis

4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer

5. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Pioglitazone Induced Reversible Pancytopenia
Experimental and Clinical Endocrinology & Diabetes, 11/02/09

Karakurt F et al. – Pioglitazone is used to improve insulin sensitivity in type 2 diabetes. The authors report a patient who developed pancytopenia on the 7th day of oral pioglitazone treatment for the control of diabetes mellitus and fully recovered 6 days after the cessation of this drug. This is the first reported case of pancytopenia induced by pioglitazone therapy.